Besides CD68, additional TAM biomarkers, such as the similarly expressed CD163 and colony-stimulating factor 1 receptor (CSF-1R) diagnostic antibody-based reagents, may be useful to stratify prognosis for HL (40, 42). The gene discussed is CSF1R; the disease is Hodgkins lymphoma.